Point72 DIFC Ltd trimmed its position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 31.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 478 shares of the technology company’s stock after selling 220 shares during the period. Point72 DIFC Ltd’s holdings in Amdocs were worth $38,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of DOX. Norwood Financial Corp bought a new position in Amdocs in the first quarter worth about $33,000. Central Pacific Bank Trust Division bought a new position in Amdocs in the first quarter worth about $53,000. Riverview Trust Co bought a new position in Amdocs in the first quarter worth about $55,000. Quarry LP raised its stake in Amdocs by 168.9% in the fourth quarter. Quarry LP now owns 656 shares of the technology company’s stock worth $58,000 after buying an additional 412 shares in the last quarter. Finally, American National Bank bought a new position in Amdocs in the second quarter worth about $76,000. 92.02% of the stock is owned by institutional investors.
Amdocs Price Performance
Shares of NASDAQ DOX opened at $87.83 on Monday. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The company has a 50 day simple moving average of $85.24 and a two-hundred day simple moving average of $83.81. The company has a market capitalization of $10.32 billion, a price-to-earnings ratio of 19.74, a P/E/G ratio of 1.54 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.24.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date is Monday, September 30th. Amdocs’s payout ratio is 42.92%.
Analyst Ratings Changes
Separately, StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 13th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $102.50.
Check Out Our Latest Report on DOX
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- Ride Out The Recession With These Dividend Kings
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 9/23 – 9/27
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.